PCSA
PCSA
NASDAQ · Pharmaceuticals

Processa Pharmaceuticals Inc

$1.89
-0.07 (-3.57%)
As of Sep 21, 6:10 PM ET ·
Analyst Consensus
Strong Buy
7
Analysts
Moderate
Coverage
Buy 6 86%
Hold 1 14%
Sell 0 0%
Price Target
Analyst Price Target +1,852.4% upside
Low Target $23.79
Average Target $36.90
High Target $41.20
Current Price $1.89
Current
$1.89
Target
$36.90
$23.79 $36.90 avg $41.20
Scenario Analysis
Bear Case
$23.79
1,158.7%
Low target
Base Case
$36.90
+1,852.4%
Avg target
Bull Case
$41.20
+2,079.9%
High target
Risk/Reward
1.8x
Balanced
Price in Context
52-Week High
$14.24
-86.7% from high
52-Week Low
$1.67
+13.2% from low
Target vs 52W High
$36.90
+159.1% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Strong Buy 38 79% $1,330.33 +14.2%
RDY
Dr. Reddy's Laboratories
Strong Sell 45 31% +0.0%
JNJ
Johnson & Johnson
Buy 31 71% $299.55 +11.2%
MRK
Merck & Co. Inc.
Buy 36 72% $159.27 +6.5%
PFE
Pfizer Inc.
Hold 36 39% $33.90 +22.2%
BMY
Bristol-Myers Squibb Co
Hold 35 43% $174.50 +178.7%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 16 88% $36.26 -38.0%
ZTS
Zoetis Inc
Hold 24 50% $209.87 +194.2%